Literature DB >> 20829541

Zinc transmetallation and gadolinium retention after MR imaging: case report.

Steven A Greenberg1.   

Abstract

A patient with chronic zinc poisoning from denture cream retained gadolinium after a magnetic resonance imaging procedure, likely due to transmetallation. During chelation therapy, high levels of gadolinium in excreted urine (up to 89 μg/d, 29 days after gadolinium administration) were present, indicating that gadolinium had been retained. Almost 2½ years after gadolinium exposure, a 24-hour urine collection indicated that the gadolinium level remained in the elevated range (0.6 μg/d). This single case report suggests that patients with elevated zinc exposure may be at increased risk of gadolinium retention. © RSNA, 2010.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20829541     DOI: 10.1148/radiol.10100560

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  11 in total

1.  Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients.

Authors:  Alessandra Splendiani; Marco Perri; Claudia Marsecano; Valentina Vellucci; Giulia Michelini; Antonio Barile; Ernesto Di Cesare
Journal:  Radiol Med       Date:  2017-09-27       Impact factor: 3.469

Review 2.  Evaluating the Patient with Reported Gadolinium-Associated Illness.

Authors:  Tatyana Lyapustina; Charlotte Goldfine; Sean Rhyee; Kavita M Babu; Matthew K Griswold
Journal:  J Med Toxicol       Date:  2018-11-29

Review 3.  Gadolinium-based contrast agents for magnetic resonance cancer imaging.

Authors:  Zhuxian Zhou; Zheng-Rong Lu
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2012-10-09

4.  Albumin-based nanoparticles as contrast medium for MRI: vascular imaging, tissue and cell interactions, and pharmacokinetics of second-generation nanoparticles.

Authors:  E A Wallnöfer; G C Thurner; C Kremser; H Talasz; M M Stollenwerk; A Helbok; N Klammsteiner; K Albrecht-Schgoer; H Dietrich; W Jaschke; P Debbage
Journal:  Histochem Cell Biol       Date:  2020-10-11       Impact factor: 4.304

Review 5.  Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms.

Authors:  Moshe Rogosnitzky; Stacy Branch
Journal:  Biometals       Date:  2016-04-06       Impact factor: 2.949

Review 6.  Gadolinium Deposition in the Brain: Current Updates.

Authors:  Jin Woo Choi; Won-Jin Moon
Journal:  Korean J Radiol       Date:  2018-12-27       Impact factor: 3.500

7.  Capturing an elusive but critical element: Natural protein enables actinium chemistry.

Authors:  Gauthier J-P Deblonde; Joseph A Mattocks; Ziye Dong; Paul T Wooddy; Joseph A Cotruvo; Mavrik Zavarin
Journal:  Sci Adv       Date:  2021-10-20       Impact factor: 14.136

Review 8.  Gadolinium Retention: A Research Roadmap from the 2018 NIH/ACR/RSNA Workshop on Gadolinium Chelates.

Authors:  Robert J McDonald; Deborah Levine; Jeffrey Weinreb; Emanuel Kanal; Matthew S Davenport; James H Ellis; Paula M Jacobs; Robert E Lenkinski; Kenneth R Maravilla; Martin R Prince; Howard A Rowley; Michael F Tweedle; Herbert Y Kressel
Journal:  Radiology       Date:  2018-09-11       Impact factor: 11.105

9.  Detection and imaging of gadolinium accumulation in human bone tissue by micro- and submicro-XRF.

Authors:  Anna Turyanskaya; Mirjam Rauwolf; Vanessa Pichler; Rolf Simon; Manfred Burghammer; Oliver J L Fox; Kawal Sawhney; Jochen G Hofstaetter; Andreas Roschger; Paul Roschger; Peter Wobrauschek; Christina Streli
Journal:  Sci Rep       Date:  2020-04-14       Impact factor: 4.379

10.  The Role of Ferrous Ion in the Effect of the Gadolinium-Based Contrast Agents (GBCA) on the Purkinje Cells Arborization: An In Vitro Study.

Authors:  Achmad Adhipatria Perayabangsa Kartamihardja; Winda Ariyani; Hirofumi Hanaoka; Ayako Taketomi-Takahashi; Noriyuki Koibuchi; Yoshito Tsushima
Journal:  Diagnostics (Basel)       Date:  2021-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.